Non classé – XENOTHERA

XENOTHERA strengthens its position in oncology and announces several clinical advances and scientific publications

October, 2025. Nantes-based biotech company XENOTHERA is accelerating its developments in oncology with several multispecific glyco-humanized antibody (GH-pAb) programs. The company today announces new clinical milestones and major publications

XENOTHERA confirms progress in the treatment of peripheral T-cell lymphoma (PTCL) through its LIS22 antibody

June, 2025, Nantes-based biotech XENOTHERA confirms the value of its LIS22 antibody in the treatment of peripheral T-cell lymphomas (PTCL). The PALT1 clinical trial (NCT06495723) has just passed a new milestone

XENOTHERA reports to ASCO on the clinical trial of its first anti-cancer drug, XON7, and announces a financing agreement with BPI France

June, 2024. During its participation in ASCO, XENOTHERA….

[Press Release] XENOTHERA recruits the first patient in the clinical trial of XON7, its new anti-cancer treatment

November 27, 2023. # Download our press release (english version) # Télécharger...

[Press Release] French biotech announces its therapeutic potential for oxygen-free patients

October 25, 2023. # Download our press release (english version) # Télécharger...

[Press Release] New hope for patients: XENOTHERA granted orphan drug designation (ODD ) from the FDA for LIS1 in the treatment of T-lymphomas.

September 12, 2023. # Download our press release (english version) # Télécharger...

[Press Release] XENOTHERA strengthens its management team and governance.

June 8, 2023. # Download our press release (english version) # Télécharger...

[Press Release] XENOTHERA publishes its results at the World Cancer Congress in Chicago (ASCO) June 2-6, 2023.

May 30, 2023. # Download our press release (english version) # Télécharger...

[Communiqué officiel] À l’occasion du déplacement du Président de la République française, Emmanuel Macron, XENOTHERA est présente en Chine pour suivre un programme Business organisé par Business France.

April 5,2023. # Télécharger notre communiqué de presse (version française)

[Press Release] The French biotech XENOTHERA, on a mission with business France in China

April 3, 2023. # Download our press release (english version) # Télécharger...

[Press Release] XAV-19, the anti-SARS-CoV-2 GH-pAb of XENOTHERA best-in-class against all variants including BQ. 1.1

January 05,2023. # Download our press release (english version)

[Press Release] XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody.

December 16,2022. # Download our press release (english version) # Télécharger notre...

[Press Release] XENOTHERA signs a memorandum of understanding with the Vietnamese conglomerate Vingroup

September 9,2021. # Download our press release (english version) # Télécharger notre...

[Press Release] 20 M€ raised by XENOTHERA to accelerate its development

June 29, 2021. # Download our press release (english version) # Télécharger...

[Press Release] Effectiveness of XAV19 against SARS-CoV-2 variants

February 1, 2021. # Download our press release (english version) # Télécharger...

[Newsletter] XENONEWS

March 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

[Press Alert] New step for XENOTHERA and the Nantes University Hospital

December 29, 2020. # Download our press information (english version) # Télécharger...

[Newsletter- 11] NEWS/INFOS

November 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

[Infography/Infographie]

November 25, 2020. # VACCINE & TREATMENT # Understanding the differences #...

[Newsletter- 10] NEWS/INFOS

October 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

[Newsletter -2] NEWS /INFOS

May 8, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Alerte actualité] Anticorps XAV19

30 avril 2020 Download the press release / Télécharger le communiqué

COVID19 / XAV19 : Scientific and medical rationale

Français ci-dessous « We are convinced that our treatment will be efficient, for...

XENOTHERA presents at Toulouse ONCOWEEK 2020

At ONCOWEEK 2020 that will take place in Toulouse on Feb. 3-5,...